BioCentury
ARTICLE | Clinical News

Onapristone ER: Phase I data

July 20, 2015 7:00 AM UTC

Data from 21 patients who had failed Zytiga abiraterone or Xtandi enzalutamide treatment in the dose-escalation Phase I portion of an open-label, U.K. Phase I/II trial showed that 10, 20, 30, 40 and...